403 related articles for article (PubMed ID: 10746412)
21. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia.
Miller WH; Kakizuka A; Frankel SR; Warrell RP; DeBlasio A; Levine K; Evans RM; Dmitrovsky E
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2694-8. PubMed ID: 1372989
[TBL] [Abstract][Full Text] [Related]
22. [Childhood acute promyelocytic leukemia treated with all-trans retinoic acid].
Hatae Y; Nakadate H; Iizuka S; Takeda T; Shikano T; Imaizumi M
Rinsho Ketsueki; 1996 Dec; 37(12):1410-5. PubMed ID: 8997131
[TBL] [Abstract][Full Text] [Related]
23. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
[TBL] [Abstract][Full Text] [Related]
24. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
25. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
26. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene.
Meloni G; Diverio D; Vignetti M; Avvisati G; Capria S; Petti MC; Mandelli F; Lo Coco F
Blood; 1997 Aug; 90(3):1321-5. PubMed ID: 9242568
[TBL] [Abstract][Full Text] [Related]
27. [Pilot study of PML/RAR alpha fusion by fluorescence in situ hybridization (FISH)method in acute promyelocyte leukemia].
Legües ME; Franco G; Bertin P
Rev Med Chil; 2002 Jul; 130(7):737-44. PubMed ID: 12235897
[TBL] [Abstract][Full Text] [Related]
28. [Molecular responses in acute promyelocytic leukemia patients monitored by real-time quantitative RT-PCR].
Yao L; Chen ZX; Cen JN
Ai Zheng; 2008 Feb; 27(2):214-7. PubMed ID: 18279625
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
Chen Z; Chen SJ; Wang ZY
C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
[TBL] [Abstract][Full Text] [Related]
30. Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemia.
Karlic HI; Mühlberger H; Pavlova BG; Pfeilstöcker M; Salamon J; Pittermann E; Heinz R; Koller E
Bone Marrow Transplant; 1995 Jun; 15(6):999-1000. PubMed ID: 7581106
[TBL] [Abstract][Full Text] [Related]
31. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.
Huang W; Sun GL; Li XS; Cao Q; Lu Y; Jiang GS; Zhang FQ; Chai JR; Wang ZY; Waxman S
Blood; 1993 Aug; 82(4):1264-9. PubMed ID: 8394752
[TBL] [Abstract][Full Text] [Related]
32. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.
Grimwade D; Howe K; Langabeer S; Davies L; Oliver F; Walker H; Swirsky D; Wheatley K; Goldstone A; Burnett A; Solomon E
Br J Haematol; 1996 Sep; 94(3):557-73. PubMed ID: 8790159
[TBL] [Abstract][Full Text] [Related]
33. [Acute promyelocytic leukemia. The therapeutic advances].
de Lacerda JF; do Carmo JA; de Lacerda JM
Acta Med Port; 1993 Oct; 6(10):473-80. PubMed ID: 8285119
[TBL] [Abstract][Full Text] [Related]
34. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
[TBL] [Abstract][Full Text] [Related]
35. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
[TBL] [Abstract][Full Text] [Related]
36. Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemia.
Seiter K; Miller WH; Feldman EJ; Ahmed T; Arlin Z
Leukemia; 1995 Jan; 9(1):15-8. PubMed ID: 7845010
[TBL] [Abstract][Full Text] [Related]
37. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
38. All-trans retinoic acid as a single agent induces complete remission in a patient with acute leukemia of M2a subtype.
Chen Z; Wang Y; Wang W; Gong J; Xue Y
Chin Med J (Engl); 2002 Jan; 115(1):58-61. PubMed ID: 11930660
[TBL] [Abstract][Full Text] [Related]
39. [Comparisons of conventional and normalized calculation of quantitative real-time RT-PCR detecting PML-RAR alpha fusion gene in patients with acute promyelocytic leukemia].
Hu J; Gao XD; Liu YF; Zhu YM; Li JM; Shen ZX
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):304-7. PubMed ID: 18844066
[TBL] [Abstract][Full Text] [Related]
40. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
